Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - HAEMONETICS CORP | b84572e8vk.htm |
Exhibit 99.1
FOR RELEASE:
|
CONTACT: | |||
Date
|
January 26, 2011 | Bryanne Salmon | ||
Time
|
4:00 pm Eastern | Tel. (781) 356-9613 | ||
| bsalmon@haemonetics.com | ||||
Paul M. Black Joins Haemonetics Board of Directors
Braintree,
MA, January 26, 2011 — Haemonetics Corporation (NYSE:HAE) announced today that the Board
of Directors elected Black to join its Board effective immediately.
Mr. Black, age 52, spent 13 years with Cerner Corporation, a publically traded global provider of
healthcare information technology solutions. He retired as Cerner’s Chief Operating Officer in
2007. Prior to Cerner, Black was with IBM from 1982 to 1994, in a number of senior sales and
professional services leadership positions.
Mr. Black currently serves on the Boards at Connextions, Inc., and Saepio Technologies, Inc.,
private companies with enterprise wide, integrated software and services information technology
offerings, as well as the Board Chairman of Truman Medical Centers, a two hospital not-for-profit
acute-care health system located in Kansas City.
Black is an Operating Executive for Genstar Capital, LLC, a San Francisco-based private equity firm
that invests in leading middle-market companies as well as an Advisor to New Mountain’s debt
effort, Guardian, which was established in 2008 to purchase debt securities.
Mr. Black has a BS degree from Iowa State University and an MBA from the University of Iowa.
Ron Gelbman, Lead Director of Haemonetics’ Board said, “Paul’s deep knowledge and experience
scaling clinical information management systems to deliver clinical benefits and cost savings make
him uniquely qualified to help guide the Company as we pursue blood management solutions that are
leveraged through clinical information management systems.”
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood
management solutions for our customers. Together, our devices and consumables, information
technology platforms, and consulting services deliver a suite of business solutions to help our
customers improve clinical outcomes and reduce the cost of healthcare for blood collectors,
hospitals, and patients around the world. Our technologies address important medical markets:
blood and plasma component collection, the surgical suite, and hospital transfusion services. To
learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
Haemonetics Corporation • 400 Wood Road • Braintree, MA 02184 USA